Product information

Current status:

Cancelled Post Market

Current status date:

2007-03-14

Original market date: ^{See footnote 1}

2002-10-02

Product name:

ORAJEL ULTRA CANKER SORE MEDICINE

DIN:

02245009 Electronic product monograph is not available

Company:

DEL PHARMACEUTICS (CANADA) INC.
316 Bayview Drive
Barrie
Ontario
Canada L4N 4Y8

Class:

Human

Dosage form(s):

Gel

Route(s) of administration:

Topical

Number of active ingredient(s):

2

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:16.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

A01AD11 VARIOUS

Active ingredient group (AIG) number:^{See footnote5}

0209434004